In line with these results, we found a decreased rate of naïve T cells (CD45RA+/CCR7+) and an increased frequency of effector memory T cells (CD45RA−/CCR7−) in the tumor microenvironment compared to PBMC of cancer patients. Here, CCR7 is linked to cancer.